Australia's largest stock trading and investment forum Australia's #1 stock forum

NTI

Click for more information

1.45%

7.0¢ neurotech international limited

Rights issue along with positive study results, page-2

First 2 Last

Share
Profile

Follow
Ckeenan

549 Posts.

22

25/09/17

10:52

Post #: 27433314
Share

Originally posted by Newrotothis ↑

One possible reason for trading halt rather than just releasing the results which have already been presented to a public forum... to use the huge share price reaction as an opportunity to raise badly needed capital.

The collapse of the Italian deal leave NTI without necessary revenues to get us through to FDA approval without having to cutback on research or marketing. European expansion has been slower than expected. However if these results are as positive as Carrick presenting them would suggest, then this is perfect opportunity to launch a fund raise for another $5m. There would be huge demand as at last we finally have proof that the technology works, and is on track for FDA.

$5m is currently 1/3rd of the market cap, but is also the expected income they have lost from the Italians. This would leave the company looking in a very healthy state post positive news + healthy balance sheet!

Without the capital raise I would expect the stock to double on Wednesday to 33p, therefore it would be roughly a 1 for 6 rights, and stock would trade around 28p post rights. I'll take that thanks.

Just a thought and purely speculation on their options.

Expand

If the Italian deal is off, why are they opening three centres to raise awareness of the product?

NTI Price at posting: 16.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Chaos reigns markets – so let's take stock of where we're at ahead of December

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

There are more pages in this discussion • 29 more messages in this thread...

First 2 Last

Add NTI (ASX) to my watchlist

(20min delay)
Last 7.0¢		Change 0.001(1.45%)		Mkt cap ! $64.55M

Open	High	Low	Value	Volume
7.1¢	7.1¢	7.0¢	$16.67K	237.0K

Buyers (Bids)

No.	Vol.	Price($)
3	75250	6.9¢

Sellers (Offers)

Price($)	Vol.	No.
7.0¢	23082	1

View Market Depth

No.	Vol.	Price($)
4	589299	0.070
1	36231	0.069
5	240000	0.068
2	255000	0.067
3	262000	0.066

Price($)	Vol.	No.
0.072	100000	1
0.074	40000	1
0.075	738582	2
0.076	90000	1
0.077	190000	3

Last trade - 14.13pm 28/11/2024 (20 minute delay)

NTI (ASX) Chart